Long-term efficacy, safety and durability of Juvederm (R) XC

被引:20
作者
Ballin, Annelyse C. [1 ]
Cazzaniga, Alex [1 ]
Brandt, Fredric S. [1 ]
机构
[1] Dermatol Res Inst, Miami, FL USA
关键词
dermal filler; hyaluronic acid; Juvederm XC; lidocaine; Juvederm; dermatologic procedures;
D O I
10.2147/CCID.S33568
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 [皮肤病与性病学];
摘要
Over the last decade, there has been increasing interest in minimally invasive cosmetic treatments, especially for facial rejuvenation. Next to botulinum toxin injection, the injection of soft tissue fillers is the second most frequent minimally invasive procedure performed in the USA. Hyaluronic acid (HA) is the most commonly used dermal filler. One of patients' main concerns about filler injections pertains to pain and discomfort. Topical anesthetics, nerve blocks, and/or the incorporation of lidocaine to the filler have been applied in order to reduce distress and pain. Despite nerve blocks being an effective form of anesthesia, they may distort the area to be treated, as well as lengthen and complicate the procedure. Studies have shown that the incorporation of lidocaine to HA fillers significantly reduces pain and discomfort. Yet, one of the dilemmas about the addition of lidocaine solution to HA fillers is the possible alteration of the physical characteristics of the product by negatively impacting the efficacy and/or duration of the filler. The concern is that the addition of lidocaine could dilute the product, creating less correction per mL, changing the product's viscosity and consequently the "lifting" ability. Also, this dilution could reduce the product's duration. There may be a difference between a physician adding an aqueous solution into a lidocaine-free version of HA and the pre-incorporated lidocaine version of HA. An aqueous solution might dilute the product, while the pre-incorporated powder lidocaine appears to avoid this problem. Juvederm((R)) XC is manufactured with powder lidocaine 0.3%; it is associated with significantly less injection pain than Juvederm((R)) and other lidocaine-free versions of HA. Studies have shown that lidocaine enhances treatment comfort and optimizes the injection experience while maintaining a similar safety and effectiveness profile. Regarding the longevity, further study is necessary to determine if there is any difference in durability.
引用
收藏
页码:183 / 189
页数:7
相关论文
共 26 条
[1]
Allemann IB, 2008, CLIN INTERV AGING, V3, P629
[2]
Allergic reactions to lignocaine [J].
Ball, IA .
BRITISH DENTAL JOURNAL, 1999, 186 (05) :224-226
[3]
Comparison of smooth-gel hyaluronic acid dermal fillers with cross-linked bovine collagen: A multicenter, double-masked, randomized, within-subject study [J].
Baumann, Leslie S. ;
Shamban, Ava T. ;
Lupo, Mary P. ;
Monheit, Gary D. ;
Thomas, Jane A. ;
Murphy, Diane K. ;
Walker, Patricia S. .
DERMATOLOGIC SURGERY, 2007, 33 (02) :S128-S135
[4]
Becker Daniel E, 2012, Anesth Prog, V59, P90, DOI 10.2344/0003-3006-59.2.90
[5]
IgE-mediated allergy to local anaesthetics: separating fact from perception: a UK perspective [J].
Bhole, M. V. ;
Manson, A. L. ;
Seneviratne, S. L. ;
Misbah, S. A. .
BRITISH JOURNAL OF ANAESTHESIA, 2012, 108 (06) :903-911
[6]
Lift capabilities of hyaluronic acid fillers [J].
Borrell, Marcos ;
Leslie, Dustin B. ;
Tezel, Ahmet .
JOURNAL OF COSMETIC AND LASER THERAPY, 2011, 13 (01) :21-27
[7]
Brandt FS, 2012, DERMATOLOGY SURG STE, P259
[8]
Campbell J R, 2001, Anesth Prog, V48, P21
[9]
Advances in facial rejuvenation: Botulinum toxin type A, hyaluronic acid dermal fillers, and combination therapies-consensus recommendations [J].
Carruthers, Jean D. A. ;
Glogau, Richard G. ;
Blitzer, Andrew .
PLASTIC AND RECONSTRUCTIVE SURGERY, 2008, 121 (05) :5S-30S
[10]
Gel Properties of Hyaluronic Acid Dermal Fillers [J].
Edsman, Katarina ;
Nord, Lars I. ;
Ohrlund, Ake ;
Larkner, Helena ;
Kenne, Anne Helander .
DERMATOLOGIC SURGERY, 2012, 38 (07) :1170-1179